HI antihistamine;Anihistaminiques H1

Revue Francaise d'Allergologie et d'Immunologie Clinique

Volumn 41, Issue 1, 2001, Pages 74-84

  Dutau, G ^a   Micheau, P ^a   Didier, A ^b   Rance F ^a   Bremont F ^a   Murris Espin, M ^b  

^a HÔPITAL DES ENFANTS   (France)

^b CHU RANGUEIL   (France)

Author keywords

Allergic rhinitis; Antiallergic drugs; Antihistamines; Asthma; Atopic dermatitis; Pr vention of allergy; Urticaria

Indexed keywords

ANTIHISTAMINIC AGENT;

ALLERGIC RHINITIS; ANTIINFLAMMATORY ACTIVITY; ASTHMA; ATOPIC DERMATITIS; CONFERENCE PAPER; DRUG EFFICACY; FRANCE; HUMAN; PRURITUS; URTICARIA;

EID: 0035150795     PISSN: 03357457     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0335-7457(01)80026-5     Document Type: Conference Paper

References (49)

1. Histamine
2. L'histamine
3. Antihistaminiques
4. International consensus report on the diagnosis and the management of rhinitis. International rhinitis management working group
5. HI-receptors antagonists: Clinical pharmacology and therapeutics
6. The metabolic profile of second generation antihistamines
7. The human hepatic cytochrome P450 involved in drug metabolism
8. Exploration clinique. Tests cutanés
9. Appraisal of the validity of histamine-induced wheal and flare to predict the clinical efficacy of antihistamines
10. Cetirizine inhibition of histamine-induced bronchospasm
11. The inhibitory effect of terfenadine and ibuprofen on early and late phase bronchoconstriction following allergen challenge in atopic asthma
12. Is there a place for antihistamines in the treatment of perennial asthma ?
13. Antiallergic activity of HI-receptor antagonists assessed by nasal challenge
14. Ketotifen. A review ot its pharmacocinetic properties, and therapeutic use in asthma and allergic disorders
15. Inhibitory effet of cetirizine 2HC1 on eosinophil migration in vivo
16. Inhibitory effet of cetirizine on allergen-induced histamine and PGD2 release and on eosinopli recruitment in allergic patients
17. Cetirizine reduces inflammatory cell recruitment and ICAM 1 (or CD54) expression on conjunctival epithelium in both early- and late-phase reactions after allergen-specific challenge
18. Inhibitory effect of loratadine on LTC4 release from human leukocytes
19. In vitro effect of loratadine on the intracellular calcium variation induced on IgE sensitized rat basophilic leukemia (RBL-2H3) and on rat hepatocytes
20. Inhibitory activity of loratadine and descarboethoxyloratadine on expression of ICAM-1 and HLA-DR by nasal epithelial cells
21. Terfenadine end fexofenadine reduce in vitro ICAM-1 expression on human continuous cell lines
22. The impact of allergic rhinitis on quality of life and other airway diseases. Summary of a European conference
23. Consensus statement on the treatment of allergic rhinitis
24. Optimiser la qualité de vie par le traitement
25. Traitement des rhinites allergiques: Quelques questions d'actualité
26. Comparison of beclomethasone dipropionate aqueous nasal spray, astemizole and the combination in the prophylactic treatment of ragweed pollen-induced rhinoconjunctivitis
27. Adding loratadine to topical nasal steroid therapy improve moderately severe seasonal allergic rhino-conjunctivitis
28. A comparison of the anti-inflammatory properties of intranasal corticosteroids and antihistamines in allergic rhinitis
29. Aqueous beclomethasone dipropionate nasal spray: Regular versus 'as required' use in the treatment of seasonal allergic rhinitis
30. A multicenter clinical study of the efficacy and tolerability of azelastine nasal spray in the treatment of seasonal allergic rhinitis: A comparison with oral cetirizine
31. Intranasal corticosteroids versus oral H1 receptor antagonists in allergic rhinitis: Systematic reviev of randomised controlled trials
32. Urticaire chronique: Progrés récents
33. The clinical efficacy of antihistamines in the skin
34. Chronic urticaria in childhood
35. Loratadine in the treatment of mosquito-bite-sensitive children
36. Antihistamine premedication in specific cluster immunotherapy: A double-blind, placebo-controlled study
37. Reduction of side-effects from ultrarush immunotherapy with honeybee venon by pretreatment with fexofenadine : A double-blind, placebo-controlled trial
38. Prevention of asthma by ketotifen in infants with atopic dermatitis
39. Prevention of asthma with ketotifen in preasthmatic children: A three-year follow-up study
40. Allergic factors associated with the development of asthma and the influence of cetirizine in a doubleblind, randomised, placebo-controlled trial: First results of ETAC
41. Rôle de l'infection virale dans la genèse de l'asthme et de l'allergie respiratoire chez l'enfant
42. Vers une stratégie de prevention chez l'enfant ?
43. Prolongation of simple and choice reaction times in a double-blind comparison of twice daily hydroxyzine versus terfenadine
44. Benefit/risk ratio of the antihistamines (Hl receptor antagonists) terfenadine and chlorpheniramine in children
45. Seasonal allergic rhinitis and histamine effects on children's learning
46. Cardiac adverse effects of Hl-anihistamines
47. Torsades de pointes after astemizole overdose
48. Torsades de pointes occuring in association with terfenadine